Informed consent in pediatric research

Cambridge Quarterly of Healthcare Ethics

Volumn 13, Issue 4, 2004, Pages 346-358

  Ross, Lainie Friedman ^a,b  

^a Department of Pediatrics ^*  (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD DEVELOPMENT; CHILD HEALTH; CHILD REARING; DECISION MAKING; FAMILY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HEALTH SURVEY; INFORMED CONSENT; LEGAL ASPECT; MEDICAL INFORMATION; MEDICAL RESEARCH; MORALITY; PEDIATRICIAN; PEDIATRICS; PERSONHOOD; PREGNANCY; PSYCHOLOGICAL ASPECT; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SEXUALLY TRANSMITTED DISEASE;

EID: 7044222039     PISSN: 09631801     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0963180104134063     Document Type: Review

References (87)

1. Nuremberg Code (1946). Reprinted in: Reich WT, ed. Encyclopedia of Bioethics: Vol. 4. New York: The Free Press; 1978:1764.
2. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Adopted by the 18th World Medical Association (WMA) General Assembly, Helsinki, Finland, June 1964, and amended by the 29th WMA General Assembly, Tokyo, Japan, October 1975, 35th WMA General Assembly, Venice, Italy, October 1983; 4th WMA General Assembly, Hong Kong, September 1989, 48th WMA General Assembly, Somerset West, Republic of South Africa, October 1996, and the 52nd WMA General Assembly, Edinburgh Scotland, October 2000. Available at: http://www.wma.net/e/policy/b3.htm. Accessed 29 May 2002.
3. Department of Health and Human Services. 45 CFR 46, subpart D: protections for children involved as subjects in research. Federal Register 1983;48:9814-20.
4. Children's Health Act of 2000. Public law 106-310. Available at: http://frwebgate.access.gpo.gov/ cgi-bin/getdoc.cgi?dbname= 106_cong_public_laws&docid=f:publ310.106.pdf. Accessed 10 Oct 2002.
5. See note 4, Children's Health Act of 2000:Title X, sect. 1003(a).
6. DHHS, Food and Drug Administration (FDA). 21 CFR 50 and 56: additional safeguards for children in clinical investigations of FDA-regulated products. Federal Register 2001;66:20589-600.
7. See note 3, DHHS 1983:sect. 46.408.
8. See note 3, DHHS 1983:sect. 46.408b.
9. See note 3, DHHS 1983:sect. 46.408c.
10. See note 3, DHHS 1983:sect. 46.408c.
11. See note 6, FDA 2001:20594 (H.H.) and codified as section 50.55e.
12. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Report and Recommendations: Research Involving Children. Washington, DC: U.S. Printing Office; 1977:13.
13. DHHS. 45 CFR 46: final regulations amending basic HHS policy for the protection of human research subjects. Federal Register 1981;46:8366-91 at section 46.116.
14. See note 13, DHHS 1981:sect. 46.116.
15. See note 3, DHHS 1983:sect. 46.408a.
16. See note 13, DHHS 1981:sect. 46.408a.
17. Buchanan AE, Brock DW. Deciding for Others: The Ethics of Surrogate Decision Making. New York: Cambridge University Press; 1989:233.
18. See note 17, Buchanan, Brock 1989:233.
19. See, for example: Ross LF. Children, Families and Health Care Decision Making. London/New York: Oxford University Press; 1998; Houlgate L. Family and State: The Philosophy of Family Law. Totowa, NJ: Rowman and Littlefield; 1988; and Schoeman F. Parental discretion and children's rights: background and implications for medical decision making. Journal of Medicine and Philosophy 1985;10:45-62.
20. See, for example: Ross LF. Children, Families and Health Care Decision Making. London/New York: Oxford University Press; 1998; Houlgate L. Family and State: The Philosophy of Family Law. Totowa, NJ: Rowman and Littlefield; 1988; and Schoeman F. Parental discretion and children's rights: background and implications for medical decision making. Journal of Medicine and Philosophy 1985;10:45-62.
21. See, for example: Ross LF. Children, Families and Health Care Decision Making. London/New York: Oxford University Press; 1998; Houlgate L. Family and State: The Philosophy of Family Law. Totowa, NJ: Rowman and Littlefield; 1988; and Schoeman F. Parental discretion and children's rights: background and implications for medical decision making. Journal of Medicine and Philosophy 1985;10:45-62.
22. See note 17, Buchanan, Brock 1989:233.
23. See note 17, Buchanan, Brock 1989:234.
24. Hamburg DA. Today's CHILDREN: Creating a Future for a Generation in Crisis. New York: Times Books; 1994:194-5.
25. Study: H.S. football deaths in 1999. USATODAY Online 29 May 2002. Available at: http://99-00.idahosports.com/articles/footballdeaths.htm. Accessed 29 May 2002.
26. See note 3, DHHS 1983:sect. 46.408b.
27. See, for example: Charlow A. Awarding custody: the best interests of the child and other fictions. In: Humm SR, Ort BA, Anbari MM, Lader WS, Biel WS, eds. Child, Parent, and State. Philadelphia, PA: Temple University Press; 1994:3-26; and Altman S. Should child custody rules be fair? University of Louisville Journal of Family Law 1996/1997;35:325-54.
28. See, for example: Charlow A. Awarding custody: the best interests of the child and other fictions. In: Humm SR, Ort BA, Anbari MM, Lader WS, Biel WS, eds. Child, Parent, and State. Philadelphia, PA: Temple University Press; 1994:3-26; and Altman S. Should child custody rules be fair? University of Louisville Journal of Family Law 1996/1997;35:325-54.
29. See, for example: Cashman T. When is a biological father really a dad? Pepperdine Law Review 1997;24:959-90; and Burns JE. Note: should marriage matter? evaluating the rights of legal absentee fathers. Fordham Law Review 2000;68:2299-349.
30. See, for example: Cashman T. When is a biological father really a dad? Pepperdine Law Review 1997;24:959-90; and Burns JE. Note: should marriage matter? evaluating the rights of legal absentee fathers. Fordham Law Review 2000;68:2299-349.
31. See, for example, note 25, Charlow 1994; see note 26, Cashman 1997; see note 26, Burns 2000.
32. See note 22, Hamburg 1994:179.
33. Smith TW. The emerging 21st century American family. General Social Survey project (GSS) Social Change Report no. 42. Chicago: National Opinion Research Center, University of Chicago; 1999:26, table 4. Available at: http://www.norc.uchicago.edu/online/emerge.pdf. Accessed 9 Oct 2002.
34. See note 22, Hamburg 1994:33.
35. See note 29, Smith 1999:29, table 6. Of note, in 1998, there was a slight increase back to 51.7 percent.
36. See note 13, DHHS 1981:sect. 46.101b2.
37. See note 3, DHHS 1983:sect. 46.401b.
38. See note 3, DHHS 1983:sect. 46.408c.
39. Marshall MF. Comment on: docket #00N-0074, April 24, 2001: interim rule: "Additional safeguards for children in clinical investigations of FDA-regulated products." 2001:1. Available at: http://ohrp.osophs.dhhs.gov/ nhrpac/documents/fda.pdf. Accessed 9 Oct 2002.
40. See note 35, Marshall 2001:2.
41. See note 35, Marshall 2001:3.
42. Sigman GS, O'Connor C. Explorations for physicians of the mature minor doctrine. Journal of Pediatrics 1991;119:520-5, at 521.
43. See note 35, Marshall 2001:3.
44. See note 35, Marshall 2001:3.
45. See note 35, Marshall 2001:4.
46. See note 12, National Commission 1977:18-9.
47. See note 35, Marshall 2001:2.
48. Veatch RM. Commentary: beyond consent to treatment. IRB: A Review of Human Subjects Research 1981;3(2):7-8.
49. Field MJ, Behrman RE, on behalf of the Institute of Medicine's Committee on Clinical Research Involving Children. Washington DC: National Academics Press; 2004.
50. See note 45, Recommendations 5.4 and 5.5.
51. See, for example, note 35, Marshall 2001; Consensus Conference on Guidelines for Adolescent Health Research. Conference proceedings: guidelines for adolescent health research. Alexandria, VA, May 19-20, 1994. Journal of Adolescent Health 1995;17:264-9; and Santelli J, Rosenfeld W, DuRant R, Rosenfeld W, Dubler N. Guidelines for adolescent health research: a position paper on the Society for Adolescent Medicine. Journal of Adolescent Health 1995;17:270-6.
52. See, for example, note 35, Marshall 2001; Consensus Conference on Guidelines for Adolescent Health Research. Conference proceedings: guidelines for adolescent health research. Alexandria, VA, May 19-20, 1994. Journal of Adolescent Health 1995;17:264-9; and Santelli J, Rosenfeld W, DuRant R, Rosenfeld W, Dubler N. Guidelines for adolescent health research: a position paper on the Society for Adolescent Medicine. Journal of Adolescent Health 1995;17:270-6.
53. See note 19, Ross 1998.
54. Ackerman TF. Fooling ourselves with child autonomy and assent in nontherapeutic clinical research. Clinical Research 1979;27:345-8.
55. See, for example: note 47, Consensus Conference 1994; note 47, Santelli, Rosenfeld, DuRant, Rosenfeld, Dubler 1995.
56. See note 19, Ross 1998:152-64; see note 46, Veatch 1981.
57. See note 46, Veatch 1981.
58. Costello JC. "If I can say yes, why can't I say no?" adolescents at risk and the right to give or withhold consent to health care. In: Humm SR, Ort BA, Anbari MM, Lader WS, Biel WS, eds. Child, Parent, and State. Philadelphia, PA: Temple University Press; 1994:490-503.
59. See note 38, Sigman, O'Connor 1991:523.
60. Sikand A, Schubiner H, Simpson PM. Parent and adolescent perceived need for parental consent involving research with minors. Archives of Pediatrics and Adolescent Medicine 1997;151:603-7.
61. Bartholome WG. Ethical issues in pediatric research. In: Vanderpool HY, ed. The Ethics of Research Involving Human Subjects: Facing the 21st Century. Frederick, MD: University Publishing Group; 1996:339-70, at 356-61.
62. See note 56, Bartholome 1996.
63. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: U.S. Printing Office; 1979. Available at: http://ohrp.osophs.dhhs.gov/ humansubjects/guidance/ belmont.htm.
64. Denham EJ, Nelson RM. Self-determination is not an appropriate model for understanding parental permission and child assent. Anesthesia and Analgesia 2002;94:1049-51.
65. See note 19, Ross 1998.
66. See note 49, Ackerman 1979:348.
67. This point has been argued by several ethicists. See, for example, note 19, Ross 1998; note 19, Schoeman 1985; and Goldstein J, Freud A, Solnit AJ. Before the Best Interests of the Child. New York: The Free Press; 1979.
68. See note 49, Ackerman 1979:348.
69. Clark RB. Speed, safety, and dignity: pediatric pharmaceutical development in an age of optimism. University of Chicago Law School Roundtable 2002;9:1-44.
70. See note 64, Clark 2002:38.
71. See note 64, Clark 2002:23, 31-2.
72. McCarthy AM, Richman LC, Hoff man RP, Rubenstein L. Psychological screening of children for participation in nontherapeutic invasive research. Archives of Pediatrics and Adolescent Medicine 2001;155:1197-203.
73. See note 67, McCarthy, Richman, Hoffman, Rubenstein 2001.
74. See note 67, McCarthy, Richman, Hoffman, Rubenstein 2001:1201. Of note, the primary motivation of the parents was also financial (p. 1201). This raises ethical questions about monetary reimbursements and incentives in pediatric research. In a recent article, Wendler et al. examine the different roles that financial reimbursements and incentives play in pediatric research, offering suggestions of when they are and are not ethically appropriate. See: Wendler D, Rackoff J, Emanuel EJ, Grady C. The ethics of paying for children's participation in research. Journal of Pediatrics 2002;141:166-71.
75. See note 67, McCarthy, Richman, Hoffman, Rubenstein 2001:1202.
76. See, for example: Ondrusek N, Abramovitch R, Pencharz P, Koren G. Empirical examination of the ability of children to consent to clinical research. Journal of Medical Ethics 1998;24:158-65; and Thompson R. Vulnerability in research: a developmental perspective on research risk. Child Development 1990;61:1-16.
77. See, for example: Ondrusek N, Abramovitch R, Pencharz P, Koren G. Empirical examination of the ability of children to consent to clinical research. Journal of Medical Ethics 1998;24:158-65; and Thompson R. Vulnerability in research: a developmental perspective on research risk. Child Development 1990;61:1-16.
78. See, for example, note 71, Thompson 1990; and Conrad B, Horner S. Issues in pediatric research: safeguarding the children. Journal of the Society of Pediatric Nurses 1997;2:163-71.
79. See, for example, note 71, Thompson 1990; see note 72, Conrad, Horner 1997.
80. See note 59, Denham, Nelson 2002:1050.
81. See note 3, DHHS 1983:sect. 46.408b.
82. Gaylin W. Competence: no longer all or none. In: Gaylin W, Macklin R, eds. Who Speaks for the Child: The Problems of Proxy Consent. New York: Plenum Press; 1982:27-54, at 51.
83. See note 76, Gaylin 1982:49.
84. See note 56, Bartholome 1996:352-3.
85. See note 62, Goldstein, Freud, Solnit 1979.
86. See note 64, Clark 2002:38.
87. See note 49, Ackerman 1979:348.